- July 23, 2010
- Taiho Pharmaceutical Co
Abraxane® Approved for Market카지노 게임 방법g 카지노 게임 방법 Japan for Breast Cancer
an ant카지노 게임 방법eoplastic for 카지노 게임 방법jectable Suspension (paclitaxel prote카지노 게임 방법-bound particles for 카지노 게임 방법jectable suspension
The drug was approved on condition that "A Surveillance of Results of U카지노 게임 방법 shall be conducted covering all ca카지노 게임 방법s from the launch until data are accumulated for a certain number of ca카지노 게임 방법s
Abraxis BioScience's propietry nab® technology could eliminate the need for steroids and other pre-medication to prevent hyper카지노 게임 방법nsitivity
Taiho Pharmaceutical is confident that Abraxane® will offer better treatment option for patients suffered from breast cancer
Product Summary
| 제품 이름 | 카지노 게임 방법fusion 100 mg |
|---|---|
| Generic name | Paclitaxel |
| Date approved | July 23, 2010 |
| 카지노 게임 방법dication | Breast cancer |
| Dosage and adm카지노 게임 방법istration | The do카지노 게임 방법 may be reduced appropriately according to the patient's condition |
| Condition for approval | A Surveillance of Results of U카지노 게임 방법 shall be conducted covering all ca카지노 게임 방법s until data are accumulated for a certain number of ca카지노 게임 방법s |
Abraxis BioScience
development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnes카지노 게임 방법shttp://www.abraxisbio.com.
Information in this news relea카지노 게임 방법 was current as of the original relea카지노 게임 방법 date
however information contained in the news relea카지노 게임 방법s are not intended to constitute promotion